For non-diabetics, semaglutides ability to affect appetite and calorie intake is the primary driver of weight loss
Nadhia Bashir @Prof Toni Vidal-Puig, @Nathan Nagel, @Prof Husna Ahmad, @Dr Saira Bano, @Prof Aneta D Tunariu, @Yousaf Ahmad, To view or add a comment, sign in - - Endocrine disorders are increasingly understood as interconnected systems, not isolated gland dysfunctions
Ozempic is the stronger choice for weight loss (up to 15% of body weight) and A1C reduction (-1.8%), while Farxiga excels in heart failure prevention (-30% hospitalizations) and chronic kidney disease protection (-39% progression)
It is important to note that while the GLP-1 component of tirzepatide likely contributes to these neurobiological effects, the additional GIP receptor activation introduces complexity
Liposomal delivery appears to improve bioavailability further, though head-to-head comparative data are limited
On average, a basic hydration IV drip can range from $100 to $300 per session